skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date

(2742) Views  (1176) Full article downloads

Authors: Antonio Gaddi, AFG Cicero, FO Odoo, A Poli A, R Paoletti

Published Date January 2007 Volume 2007:3(6) Pages 877 - 886
DOI: http://dx.doi.org/10.2147/VHRM.S

Antonio Gaddi1, AFG Cicero1, FO Odoo2, A Poli A3, R Paoletti4

On behalf of the Atherosclerosis and Metabolic Diseases Study Group 1Center for Metabolic diseases and Atherosclerosis, University of Bologna, Italy; 2Creighton University Medical Center, Omaha, NE, USA; 3Nutrition Foundation of Italy, Milan, Italy; 4Department of Pharmacological Sciences, University of Milan, Milan, Italy

Abstract: Familial combined hyperlidemia (FCH) is a common metabolic disorder characterized by: (a) increase in cholesterolemia and/or triglyceridemia in at least two members of the same family, (b) intra-individual and intrafamilial variability of the lipid phenotype, and (c) increased risk of premature coronary heart disease (CHD). FCH is very frequent and is one of the most common genetic hyperlipidemias in the general population (prevalence estimated: 0.5%–2.0%), being the most frequent in patients affected by CHD (10%) and among acute myocardial infarction survivors aged less than 60 (11.3%). This percentage increases to 40% when all the myocardial infarction survivors are considered without age limits. However, because of the peculiar variability of laboratory parameters, and because of the frequent overlapping with the features of metabolic syndrome, this serious disease is often not recognized and treated. The aim of this review is to define the main characteristics of the disease in order to simplify its detection and early treatment by all physicians by mean of practical guidelines.

Keywords: familial combined hyperlipidemia, guidelines, diagnosis, management








Readers of this article also read:

Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Change in the prevalence of obesity and use of health care in Denmark: an observational study
Walking just after a meal seems to be more effective for weight loss than waiting for one hour to walk after a meal
Critical review of cancer risk associated with angiotensin receptor blocker therapy
Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy
Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options
Nebivolol: impact on cardiac and endothelial function and clinical utility
Major risk factors for the appearance of white-matter lesions on MRI in hypertensive patients with controlled blood pressure
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University